ClinicaliQ Trial Snapshot
- GLycaemic Outcomes With Whey Protein in ageING — Recruiting • Non-phase study • Diabetes / Metabolic • NCT07285811.
- What is being tested: A placebo-controlled trial investigating whether consuming whey protein before meals improves glucose control in older adults with type 2 diabetes, using a partial crossover design to assess real-world effectiveness.
- Patient eligibility overview: The study focuses on older adults diagnosed with type 2 diabetes living in community settings, examining how this intervention performs in free-living conditions rather than controlled laboratory environments.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The goal of this placebo-controlled, partial crossover design study is to identify the impact of consuming whey protein before meals on free-living glucose control in older adults living with type 2 diabetes. The primary specific objective is to determine the effect of a thrice daily whey protein pre-meal supplementation at two doses, on glucose excursions over a 7-day free-living period in adults aged 70-90 years of age, living with type 2 diabetes, compared with a non-protein placebo. Participants will consume the whey protein and placebo for 7 days each, before…
Eligibility Snapshot
- * Male or female * 70-90 years old * Type 2 Diabetes (confirmed with glycated haemoglobin (HbA1c) >6.5% in clinic or in SportExR) * Stable body mass (body mass index (BMI) ≤40kg/m2) * Generally healthy, assessed via a General Health Questionnaire (GHQ) * Some residual beta-cell activity (confirmed with urine test on induction) * Normal or moderately increased albuminuria (needs to be below 300mg/g) * Normal, mildly or moderately decreased glomerular filtration rate (GFR) (needs to be above 45ml/min/1.732). * Able and willing to attend SportExR a total of 5 times: 1 induction and 2 testing visits and 2 return check-up visits.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.